Results Press Release
Natco Pharma Ltd has submitted to BSE a copy of Results Press Release for the period ended March 31, 2014.29-05-2014
29-05-2014
Financial Results for March 31, 2014
Natco Pharma Ltd has informed BSE about the Financial Results for the period ended March 31, 2014.29-05-2014
Closure of Trading Window
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2014, inter alia, to consider & approval of the Audited Results for the quarter ending March, 2014 along with Audited Annual Accounts for the year 2013-2014.Further note that Trading Window for dealing in the securities of the company will be closed from May 20, 2014 to May 31, 2014 (both days inclusive). Trading window will be opened from June 02, 2014.20-05-2014
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201130-04-2014
Breckenridge/NATCO files ANDA For Bendamustine Hydrochloride powder
Natco Pharma Ltd has informed BSE regarding a Press Release dated April 28, 2014 titled "Breckenridge/NATCO files ANDA For Bendamustine Hydrochloride powder".28-04-2014
NATCO Pharma pleased with Federal Circuits decision on Oseltamivir
Natco Pharma Ltd has informed BSE regarding a Press Release dated April 24, 2014, titled "NATCO Pharma pleased with Federal Circuits decision on Oseltamivir".24-04-2014
Supreme Court Chief Justice denies Teva's Request for an Injunction Relating to Generic Copaxone; Clears Legal Hurdle for Mylan & Natco to Launch the same at Market Formation
Natco Pharma Ltd has informed BSE regarding a Press Release dated April 21, 2014 titled "Supreme Court Chief Justice denies Teva's Request for an Injunction Relating to Generic Copaxone; Clears Legal Hurdle for Mylan & Natco to Launch the same at Market Formation".21-04-2014
Shareholding Pattern for March 31, 2014
Natco Pharma Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March 31, 2014.12-04-2014
United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone(R) for the Second Time
Natco Pharma Ltd has informed BSE regarding a Press Release dated April 04, 2014 titled "United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone(R) for the Second Time".04-04-2014